CRON

2.63

0.75% -0.02

Handel nachbörslich: 2.62 -0.010 -0.38%

Cronos Group Inc (CRON)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$2.65

Offen:

$2.65

24-Stunden-Volumen:

1.07M

Relative Volume:

0.77

Marktkapitalisierung:

$989.59M

Einnahmen:

$146.59M

Nettoeinkommen (Verlust:

$-2.93M

KGV:

-107.79

EPS:

-0.0244

Netto-Cashflow:

$-190.40K

1W Leistung:

-0.75%

1M Leistung:

+3.95%

6M Leistung:

+7.35%

1J Leistung:

+38.42%

1-Tages-Spanne:

$2.62

$2.70

1-Wochen-Bereich:

$2.55

$2.73

52-Wochen-Spanne:

$1.83

$3.43

Cronos Group Inc Stock (CRON) Company Profile

Firmenname

Cronos Group Inc

Sektor

Healthcare (1106)

Branche

Drug Manufacturers - Specialty & Generic (84)

Telefon

(416) 504-0004

Adresse

4491 CONCESSION RD 12, STAYNER, ON

Mitarbeiter

610

Twitter

@cronosgroup

Nächster Verdiensttermin

2026-05-11

Neueste SEC-Einreichungen

CRON's Discussions on Twitter

Compare CRON vs TAK, ZTS, TEVA, HLN, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CRON Cronos Group Inc	2.63	997.12M	146.59M	-2.93M	-190.40K	-0.0244
TAK Takeda Pharmaceutical Co Adr	16.55	52.32B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	112.54	47.38B	9.47B	2.67B	2.28B	6.0218
TEVA Teva Pharmaceutical Industries Ltd Adr	35.86	41.16B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.17	41.02B	14.54B	2.22B	2.58B	0.4871
UTHR United Therapeutics Corp	572.20	24.67B	3.18B	1.33B	1.04B	27.90

Cronos Group Inc Stock (CRON) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-01-27	Eingeleitet	Canaccord Genuity	Buy
2022-11-02	Eingeleitet	Bernstein	Mkt Perform
2022-07-28	Hochstufung	Canaccord Genuity	Hold → Buy
2022-05-11	Hochstufung	CIBC	Neutral → Sector Outperform
2022-03-22	Hochstufung	Barclays	Underweight → Equal Weight
2022-01-27	Hochstufung	Jefferies	Underperform → Hold
2021-11-18	Fortgesetzt	BofA Securities	Underperform
2021-04-28	Fortgesetzt	BofA Securities	Underperform
2021-02-22	Herabstufung	CIBC	Sector Outperform → Neutral
2020-06-24	Hochstufung	Raymond James	Mkt Perform → Outperform
2020-04-27	Herabstufung	Raymond James	Outperform → Mkt Perform
2020-04-14	Herabstufung	Piper Sandler	Overweight → Neutral
2020-04-02	Herabstufung	BofA/Merrill	Buy → Neutral
2020-03-31	Herabstufung	Canaccord Genuity	Hold → Sell
2020-03-04	Hochstufung	MKM Partners	Neutral → Buy
2020-03-03	Herabstufung	Stifel	Buy → Hold
2019-10-18	Hochstufung	Stifel	Hold → Buy
2019-09-20	Eingeleitet	MKM Partners	Neutral
2019-09-05	Hochstufung	BMO Capital Markets	Underperform → Market Perform
2019-08-13	Eingeleitet	Piper Jaffray	Overweight
2019-08-09	Hochstufung	Canaccord Genuity	Sell → Hold
2019-06-28	Eingeleitet	Consumer Edge Research	Equal Weight
2019-06-06	Eingeleitet	Stifel	Hold
2019-06-05	Hochstufung	BofA/Merrill	Underperform → Buy
2019-04-17	Eingeleitet	BofA/Merrill	Underperform
2019-03-27	Herabstufung	Canaccord Genuity	Hold → Sell
2019-02-25	Eingeleitet	Jefferies	Underperform
2019-01-18	Eingeleitet	CIBC	Sector Outperform

Alle ansehen

Cronos Group Inc Aktie (CRON) Neueste Nachrichten

May 04, 2026

Cronos Group (CRON) Expected to Announce Quarterly Earnings on Monday - MarketBeat

May 04, 2026

May 01, 2026

Cronos Group Inc. to Hold Virtual 2026 Annual Meeting of Shareholders - The Manila Times

Apr 29, 2026

Cronos Group (TSE:CRON) Trading Down 1.6%Here's What Happened - MarketBeat

Apr 29, 2026

Apr 28, 2026

Cronos Group Inc. stock falls Tuesday, underperforms market - MarketWatch

Apr 28, 2026

Apr 27, 2026

Assessing Cronos Group’s Valuation As U.S. Marijuana Rescheduling Rekindles Investor Interest - Yahoo Finance

Apr 27, 2026

Is Cronos Story Shifting In TSX Small Cap Index Space? - Kalkine Media

Apr 27, 2026

Cronos grows international footprint in Switzerland - MSN

Apr 27, 2026

Apr 26, 2026

Earnings Snapshot: Cronos net revenue rises by 28% year-over-year in Q1 - MSN

Apr 26, 2026

Apr 25, 2026

Akanda Shares Soar As Cannabis Stocks Rise On US Policy Change - Sahm

Apr 25, 2026

Apr 24, 2026

Cronos Group Inc. stock rises Friday, outperforms market - MarketWatch

Apr 24, 2026

UPDATE 2-Cannabis shares retreat after initial rally on narrow scope of US rescheduling - Sahm

Apr 24, 2026

Cronos Group (NASDAQ: CRON) plans 2026 virtual meeting, director and pay votes - Stock Titan

Apr 24, 2026

UPDATE 1-Cannabis shares retreat after initial rally on narrow scope of US rescheduling - Sahm

Apr 24, 2026

CRON Stock Falls as Cannabis Sector Reassesses Market Impact - GuruFocus

Apr 24, 2026

Cannabis shares retreat after initial rally on narrow scope of US rescheduling - Reuters

Apr 24, 2026

Cronos Group (CRON) Sees Decline After Initial Surge on Marijuan - GuruFocus

Apr 24, 2026

Cannabis selloff hits CRON, ACB, CGC, TLRY, OGI as reclassification seen limited - Seeking Alpha

Apr 24, 2026

Apr 23, 2026

Cronos Group Inc. stock falls Thursday, underperforms market - MarketWatch

Apr 23, 2026

Cronos Group (NASDAQ:CRON) Shares Gap UpTime to Buy? - MarketBeat

Apr 23, 2026